University of Illinois at Chicago

UIC’s campus-wide COVID-19 efforts

4-Jun-2020 11:55 AM EDT, by University of Illinois at Chicago

Newswise — The University of Illinois at Chicago is working on a host of projects with a mission to assist patients, health care providers and first-responders as they treat people with COVID-19 and prevent the further spread of the virus.

The UIC Innovation in COVID-19 Working Group (ICWG) was formed under the auspices of Dr. Mark Rosenblatt, dean of the College of Medicine, who recognized the power of uniting the creative resources spread among various colleges in UIC’s response to the pandemic.

“UIC has a strong legacy of public-serving research and innovation, which makes us well-positioned to brainstorm and advance interdisciplinary solutions,” Rosenblatt said. “Our faculty, staff and researchers from across campus responded immediately to the call to organize and collaborate to address the various and complex challenges posed by the pandemic.”

The ICWG was organized at UIC to assign resources to and manage COVID-19 medical-related projects, said Peter Pfanner, executive director of the UIC Innovation Center. Pfanner co-leads the working group with Dr. Yannek Leiderman, associate professor of ophthalmology, who also helped organize the group.

The UIC Innovation Center works with major corporations and nonprofits, including OSF Healthcare, Caterpillar, City Tech, and Intuitive Surgical, and runs internally funded medical R&D labs, which focus on urology, ophthalmology and medical device development. The internal medical labs shifted focus to COVID-19 related activities to support the needs of UI Health — UIC’s academic and clinical health enterprise —and the College of Medicine and to potentially bring new health care products to the marketplace.

The interdisciplinary projects are being coordinated and worked on through the Innovation Center in partnership with many different colleges at UIC, including the College of Medicine; the College of Engineering; the College of Architecture, Design, and the Arts (CADA), and the College of Nursing. This collaboration brings together centers of innovation across the university with stakeholders at the medical center.

The ICWG is in constant communication with various colleges on campus, officials from UI Health and others on the front lines of treatment. Health care providers were invited to team up with designers and engineers in order to rapidly come up with solutions, said Leiderman, a biomedical device researcher and retinal surgeon who leads the Vitreoretinal Microsurgery Laboratory and the clinical imaging division in the department of ophthalmology and visual sciences.

“The greatest unmet need has been protecting frontline providers,” Leiderman said. “If you’re a doctor, a nurse or other health professional treating a patient in respiratory distress related to COVID-19, the types of procedures and life-saving treatments that are performed may place the whole provider team at risk.”

The projects include:

Face Masks: A need became apparent after Illinois advised all residents to wear masks when they leave home, and UI Health adopted universal masking of all patients, visitors and staff in its hospital and clinics to minimize spreading the infection to others, including health care providers. Knowing that demand would rapidly outstrip commercial supplies, CADA came up with a design for a reusable mask and partnered with costume designers with the Chicago Shakespeare Theater to fabricate thousands of masks that were later provided to UI Health. The project, which is being funded by UIC’s leadership, was the idea of CADA Dean Rebecca Rugg and has distributed 50,000 masks to date.

“The live arts were immediately hit hard by this pandemic,” Rugg said. “Places, where people gather, became a public health hazard, so productions and theaters were closed, and some nonprofits have needed to lay people off. This felt like a way to help the health system and help the unexpectedly unemployed fabricators in the theater industry.”

Face Shields: In addition to face masks, the group came up with a design for a face shield to cover the face and neck area from saliva and other droplets from patients who are potentially infectious. This type of protection became the optimal second-line of defense but also is becoming scarcer as the pandemic continues. The College of Engineering’s MakerSpace and UIC’s Richard and Loan Hill Department of Bioengineering teamed up to fabricate the shields and even got a local business partner to procure 1,100 feet of plastic from Atlanta and Los Angeles and deliver it directly to campus. Eric Schmidt, associate director of the MakerSpace; Dylan Lynch, the assistant director of UIC Engineering’s undergrad on-campus design and production facility; and Miiri Kotche, a clinical professor in bioengineering, were instrumental in the endeavor, which also involved the Innovation Center. The designs are also publicly available.

“I am proud of the teams that have combined expertise from across UIC to find innovative ways to contribute to the coronavirus effort,” said Peter Nelson, dean of the College of Engineering. “It’s inspiring and gratifying to know that the face shields produced in the MakerSpace have been used by health care providers in our community.”

Respirator Mask: Also known as an N95 facemask, the respirator is intended to protect the wearer from infection and is a critical element in protecting first-responders and hospital staff involved in the care of people suspected to have contracted the virus. Faculty from bioengineering, chemical engineering, and electrical and computer engineering are working together with faculty from the School of Public Health and others to make a new, improved N95 product a reality, Nelson said.

“What we designed is something that someone can make at home that is much more effective than a bandana or even a regular surgical face mask,” Leiderman said.

Test Kit Nasal Swabs: Among the major needs for COVID-19 testing is test kit nasal swabs that are used to obtain samples from patients. The Innovation Center is working on creating a new nasal swab that would fill the need and work better. Leiderman said the technical challenge is that while swab samples from patients are potentially infectious, the viral genetic material can degrade and give a negative test result if not handled properly, resulting in a so-called false-negative test. The center is currently working on a 3D-printed solution that would replace the current swabs with a more effective design that will be more sensitive, make the test procedure potentially less invasive and should lead to fewer false-negative tests.

“While we are trying to manufacture an existing design, we are also designing a swab that does a better job; in that sense, to improve the whole testing procedure and have more accurate tests come back,” Pfanner said.

Intubation Protection: Among the areas of need communicated by front-line providers was the risk of performing intubations and transporting patients within health care settings— for example from the emergency room to a hospital bed. UIC is working on a protection system that can allow multiple providers to work simultaneously over the head and upper chest area of a patient, like when a breathing tube is administered. The idea is that there will be a clear, transparent barrier through which providers can put their hands and care for the patient while being protected from potentially infectious respiratory droplets.

In addition, the center has begun working on a project that would help protect newborns from contracting the virus by airborne droplets.

“I’m really proud of the entire UIC team for banding together and the collaboration among front-line providers, doctors, nurses and others in the clinical enterprise with the innovation community at UIC,” Leiderman said. “We are united in directing our efforts and the resources of our centers of biomedical innovation to the most serious problems confronting our front-line clinical providers battling COVID-19.”




Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.81834